BD company Wikipedia
The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. Quality of care, cost efficiency, healthcare worker and patient safety and experience
Becton, Dickinson and Company (BD; also Becton Dickinson or Becton) is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD can help you identify potential “at-risk” patients, empower clinical intervention, and advance health system insights A unique ecosystem to collaborate on flow cytometry panel design, improve cytometer efficiency and manage your laboratory. An interactive tool containing key cell information to help plan your flow cytometry experiments. The BD Rhapsody™ single-cell platform has been a key tool for the publication of our clinical research.
Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. Bard, Inc. and its parent company BD were fined $60 million USD for failing to adequately inform patients about health risks related to their transvaginal mesh devices. BD Medical’s Consulting services are primarily targeted at hospitals, healthcare systems and networks of healthcare providers.citation needed A comprehensive suite of trusted products, integrated solutions, useful tools and a wealth of information to advance your flow cytometry applications. The name “embecta” represents the company’s commitment to people living with diabetes and its corporate heritage, with the “em-” prefix evoking empathy for people living with diabetes and the empowerment of the new company and the “bect” imbibed from Becton.
- This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products.
- A unique ecosystem to collaborate on flow cytometry panel design, improve cytometer efficiency and manage your laboratory.
- We know that possibilities are endless when people feel supported and inspired.
- BD announced that it notified customers about the recall by letter and has been working with the U.S.
- Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™.
Health and safety issues
Fill out the form to receive updates on our latest products and innovations, exclusive promotions, educational tours, and other exciting news. Backed by cutting-edge technology and more than 50 years of flow cytometry expertise Designed and validated for use with cell suspensions, whole blood and tissue pieces.
The lawsuit touched off a series of legal conflicts between the companies. The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson. We know that possibilities are endless when people feel supported and inspired. At BD, we believe that people are at the heart of every breakthrough, solution, and step forward. BD can help you optimize clinical effectiveness to help drive improvement in patient outcomes
BD stated that the use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death. In February 2010 BD announced a voluntary product recall of certain lots of BD Q-Syte Luer Access Devices and BD Nexiva Closed IV Catheter Systems. In April 2016, the Occupational Safety and Health Administration fined BD US$112,700 for safety violations. The company’s line of plastic conical screwtop test tubes, known as ‘Falcon tubes’, is popular and the term is sometimes used as a generic term for such tubes. In certain places, BD Medical also offers consulting and analytics related services. In 2024, BD announced it would acquire Edwards Lifesciences’ critical care unit for $4.2 billion.
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
BD Horizon RealViolet™ 544 Reagents offer limited spillover, robust intracellular performance and lot-to-lot consistency. In December 2025, BD was sued by Tela Bio Inc., makers of a ovine forestomach matrix hernia mesh, who alleged that BD engaged in anticompetitive practices to push Tela out of the market for surgical meshes while raising prices for providers and patients. In March 2021 BD announced a recall of infusion sets for CC, GP, VP, GW/GW800, SE, and IVAC 590 Alaris Pumps and gravity infusion sets and connectors following the news that a supplier falsified sterilisation documents going back ten years. BD announced that it notified customers about the recall by letter and has been working with the U.S. The recall was initiated on Oct. 28, 2009 after BD received complaints of problems due to air entry through a part of the device.
Quality standards, cost controls and efficiency
Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™. Surgical efficiency, patient safety and outcomes, procedural cost management Use a variety of training courses for instruments and applications to take full advantage of the capabilities of BD products. Explore our khelovip webinar series spanning a broad range of topics and in-depth reviews by senior scientists, professionals and clinicians.
Health and safety issues
Houses many of our pre-designed multicolor flow cytometry panels. Explore a variety of tools for your multicolor flow cytometry, from panel design to selection tools—an array of aids to support your research. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform. It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention.